Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect

Cancer is the second cause of death in the world and the discovery of novel anticancer agents is of vital importance to provide better therapeutic options for cancer patients. In this study, a new series of 12 arylidene hydrazone phenanthrotriazine derivatives were designed, synthesized, and tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Edraki, Najmeh, Jamei, Mohammad Hasan, Haghighijoo, Zahra, Kayani, Zahra, Raufi, Elaheh, Eskandari, Masoomeh, Firouzi, Maryam, Sadeghpour, Hossein, Miri, Ramin, Khoshneviszadeh, Mehdi, Firuzi, Omidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653689/
https://www.ncbi.nlm.nih.gov/pubmed/34904005
http://dx.doi.org/10.22037/ijpr.2021.114371.14835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653689/
https://www.ncbi.nlm.nih.gov/pubmed/34904005
http://dx.doi.org/10.22037/ijpr.2021.114371.14835

Ejemplares similares